Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial (455606)

ARTG ID

455606

ARTG Name

DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

March 28, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Janssen-Cilag Pty Ltd

Sponsor Item Name

JANSSEN-CILAG PTY LTD

Active Ingredients

Ingredient Name

daratumumab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial (455606) - TGA 批准文号 | MedPath